— Know what they know.
Not Investment Advice

CV NASDAQ

CapsoVision, Inc.
1W: +1.1% 1M: -2.5% 3M: +1.8% YTD: -34.1% 1Y: +37.8%
$6.75
-0.14 (-2.03%)
 
Weekly Expected Move ±6.0%
$6 $7 $7 $7 $8
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Buy · Power 66 · $359.2M mcap · 4M float · 4.16% daily turnover · Short 71% of daily vol
Credit Risk of going bust: lower than 65% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), CapsoVision, Inc. would be worth roughly what it owes.
Total debt $687K against a stock market value of $359.2M.
Distance to default 6.83 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $344K (short-term plus half of long-term), stock volatility 95.8%; Altman Z 23.26. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-07-18
Earliest Filing
2026-03-13
Latest Filing
supplier: 1 partner: 1

Counterparties (Filed by CV)

2 relationships

Companies named in CV's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Canon Inc. CAJFF supplier Development agreement for CMOS image sensor samples and clinical evaluation of capsule endoscopies. 2026-03-13 View
Canon Inc. CAJFF partner Development agreement for CMOS image sensor samples and future purchase of sensors. 2025-07-18 View
Recent 8-K Filings (19)
Filing Date Description Type SEC
2026-09-28 Other Events; Exhibits View
2026-09-18 Material Agreement; Exhibits Agreement View
2026-08-18 Other Events; Exhibits View
2026-08-13 Material Agreement; Earnings Release; Exhibits Agreement View
2026-07-02 Officer/Director Change; Regulation FD View
2026-06-12 Shareholder Vote View
2026-05-14 Earnings Release; Exhibits View
2026-03-26 Earnings Release; Exhibits View
2026-03-20 Material Agreement; Earnings Release; Unregistered Equity Sales; Regulation FD; Other Events; Exhibi Agreement View
2026-03-13 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-12-29 Other Events; Financial Statements and Exhibits View
2025-11-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-10 Other Events; Financial Statements and Exhibits View
2025-11-03 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-09-26 Departure/Election of Directors; Appointment of Officers View
2025-09-03 Departure/Election of Directors; Appointment of Officers View
2025-08-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-18 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-07-03 Entry into Material Definitive Agreement; Amendments to Articles of Incorporation or Bylaws; Other E Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms